Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Perintis Triniti Properti Tbk. (TRIN)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Perintis Triniti Properti Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Perintis Triniti Properti Tbk. diperdagangkan di Rp414 (kapitalisasi pasar 1,87 T, volume 24 jam 31,81 jt). Perbedaan utamanya: Perintis Triniti Properti Tbk. jauh lebih besar — sekitar 17,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRIN | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,87 T |
Volume | — | 31,81 jt |
Lot | — | 318,13 rb |
Perputaran | — | 12,84 M |
Harga Rata-rata | — | 403,61 |
Nilai Transaksi | — | 12,84 M |
Harga Ekuilibrium Indikatif | — | 414 |
Volume Ekuilibrium Indikatif | — | 6,57 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Perintis Triniti Properti Tbk.
PT Perintis Triniti Properti Tbk (the Company) was established dated March 13, 2009 based on Notarial Deed No. 06 of Drs. Arif Djohan Tunggal, S.H., M.H., M.Kn., Notary in Jakarta.
Selengkapnya di halaman TRIN →
